There is no shortage of issues gripping America’s attention today, but many ID clinicians face daily the consequences of the opioid epidemic. As a medical student during the 1980s in New York City, I learned about endocarditis as well as some HIV and HBV infections arising from patient struggles with addiction.
When ID specialists were involved in the care of patients with certain kinds of drug-resistant infections, the patients’ 30-day mortality rates were about 50 percent lower, according to a new study published in Open Forum Infectious Diseases.
During a recent briefing on Capitol Hill sponsored by IDSA, HIVMA, SHEA and PIDS, several Society members shared their insights on the essential contributions of ID and HIV physicians and scientists to patient care, public health and research, as well as policy recommendations to secure the future of this workforce.
IDSA and HIVMA offer multiple opportunities to acknowledge members who have made significant contributions to the field of ID and who have achieved professional excellence. Nominate your colleagues today for the IDSA Society Awards as an excellent way to recognize their efforts and accomplishments. The deadline for nominations is April 1.